Clinical studies recruiting near Wichita

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valve
NA · Cardiovascular Research Institute of Kansas · Edwards Lifesciences · NCT05172973 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Cancer Center of Kansas ( Site 0004) · Merck Sharp & Dohme LLC · NCT06393374 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Wesley Medical Center · National Cancer Institute (NCI) · NCT06172296 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Heartland Research Associates, LLC - An AMR Company · Kallyope Inc. · NCT07674654 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Ascension Via Christi Hospitals Wichita · NRG Oncology · NCT05624996 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Cancer Center of Kansas-Wichita Medical Arts Tower · Alliance for Clinical Trials in Oncology · NCT07321652 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Wichita Falls Heart Clinic · Amgen · NCT07037433 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Ascension Via Christi Hospitals Wichita · NRG Oncology · NCT05946213 Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Phase 2 · Wichita Urology Group · CG Oncology, Inc. · NCT06567743 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Kansas Nephrology Research Institute, LLC · Boehringer Ingelheim · NCT06531824 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Cancer Center of Kansas, Heritage Plaza Medical Building · Amgen · NCT07005128 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Wichita Nephrology Group · Boehringer Ingelheim · NCT07220083 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Cancer Center of Kansas-Wichita Medical Arts Tower · NRG Oncology · NCT05174169 Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing
NA · Cardiovascular Research Institute of Kansas · University of British Columbia · NCT04634240 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Wichita Urology Group · Janssen Research & Development, LLC · NCT06319820 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Cancer Center of Kansas-Wichita Medical Arts Tower · Alliance for Clinical Trials in Oncology · NCT06876714 Pan Tumor Rollover Study
Phase 2 · Local Institution - 0165 · Bristol-Myers Squibb · NCT03899155 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Cancer Center of Kansas · Bristol-Myers Squibb · NCT06561386 Prevail Global Study
NA · Ascension Via Christi Saint Francis · Medtronic Vascular · NCT06535854 Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusi
Phase N/A · Cancer Center of Kansas · Bayer · NCT04142437 Abbott Cephea Mitral Valve Disease Registry
Phase N/A · Via Christi Regional Medical Center - St. Francis Campus · Abbott Medical Devices · NCT07069673 A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Alb
Phase 2 · Research Site · AstraZeneca · NCT07222917 SELUTION 4 De Novo Small Vessel IDE Trial
NA · Cardiovascular Research Institute of Kansas · M.A. Med Alliance S.A. · NCT05946629 Project: Every Child for Younger Patients With Cancer
Phase N/A · Wesley Medical Center · Children's Oncology Group · NCT02402244 Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Phase 2/Phase 3 · Corxel Investigational Site · Corxel Pharmaceuticals · NCT06990867 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Cancer Center of Kansas-Wichita Medical Arts Tower · ECOG-ACRIN Cancer Research Group · NCT04566328 A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Phase 3 · Tekton Research - Wichita, KS · Ardelyx · NCT07382167 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Cancer Center of Kansas-Wichita Medical Arts Tower · NRG Oncology · NCT04852887 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 1016 · Anthos Therapeutics, Inc. · NCT05712200 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109

Look up another city

Look up another condition